Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants.
Completed
- Conditions
- Preterm infantsmechanical ventilationBPDCortico steroidshydrocortisone
- Registration Number
- NL-OMON26029
- Lead Sponsor
- Academisch Medisch Centrum Amsterdam
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 400
Inclusion Criteria
Preterm infants with:
1. A gestational age < 30 wks and/or birth weight < 1250 g;
Exclusion Criteria
1. Chromosomal defects (e.g. trisomy 13, 18, 21);
2. Major congenital malformations that:
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measure is survival free of BPD at 36 weeks postmenstrual age (PMA).
- Secondary Outcome Measures
Name Time Method Short term effects on the pulmonary condition, adverse effects during hospitalization, and long-term neurodevelopmental sequelae assessed at 2 years corrected gestational age (CGA).